Permits; Applications, Issuances, etc.: Pesticide Experimental Use

An individual opposes the proposed action, expressing concerns about the ecological impact of eradicating a species and the potential for sterile mosquitoes to still transmit diseases. The commenter argues against the feasibility and safety of the project.

A private individual from Florida opposes the issuance of pesticide experimental use permits, expressing concern that large corporations will use states as "guinea pigs" for testing with unknown negative side effects. The commenter urges the EPA to prioritize environmental protection over corporate interests.

A private citizen from Vermont opposes the issuance of experimental use permits for mosquito-related projects, specifically citing concerns about "Google Mosquitoes" and gene-altering measures. The commenter argues that such projects pose unknown risks to human health, wildlife, and the natural world, and urges the EPA to deny approval.

An individual is urging the EPA to deny the proposal to release 64 million laboratory-modified mosquitoes in Florida and California. The commenter argues that the scale of the release poses unknown long-term ecological risks and that the burden of proof for safety has not been sufficiently met.

Mario C opposes the EPA's proposal to release laboratory-modified mosquitoes in Florida and California due to concerns about irreversible ecological consequences and the lack of long-term safety data. The commenter argues that the burden of proof should rest on the proponents to provide independent, long-term evidence of safety before such a large-scale biological intervention occurs.

Lorraine S. opposes the proposed release of laboratory-modified mosquitoes in Florida and California, citing concerns over the irreversible nature of biological interventions in complex ecosystems. The commenter argues that the EPA should require more independent, long-term ecological studies to prove the absence of significant risks before granting authorization.

The commenter, an individual, opposes the EPA's proposal to release 64 million laboratory-modified mosquitoes in Florida and California. They argue that the scale of the release poses unpredictable ecological risks and demand independent, long-term studies to prove environmental safety before authorization is granted.

Amber Gibson, a concerned citizen, opposes the issuance of an Experimental Use Permit for Google LLC's release of Wolbachia-treated mosquitoes. She argues that the release poses risks to ecosystems, lacks long-term health data, and deprives local residents of informed consent.